Joan Brown
Finanzdirektor/CFO bei ALLARITY THERAPEUTICS, INC.
Aktive Positionen von Joan Brown
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| ALLARITY THERAPEUTICS, INC. | Finanzdirektor/CFO | 29.06.2022 | - |
| Corporate Officer/Principal | 21.09.2021 | 29.06.2022 | |
Allarity Therapeutics A/S
 Allarity Therapeutics A/S Pharmaceuticals: MajorHealth Technology Allarity Therapeutics A/S is a biotechnology company, which engages in the research and development of anti-cancer drugs. Its product pipeline includes LiPlaCis, 2X-121, 2X-111, irofulven phase 2, and APO010.The company was founded by Steen Meier Knudsen and Peter Buhl Jensen in 2004 and is headquartered in Hoersholm, Denmark. | Finanzdirektor/CFO | 01.06.2022 | - |
Karriereverlauf von Joan Brown
Ausbildung von Joan Brown
| Simon Fraser University | Undergraduate Degree |
Statistik
International
| Kanada | 2 |
| Dänemark | 2 |
| Vereinigte Staaten | 2 |
Operativ
| Director of Finance/CFO | 2 |
| Corporate Officer/Principal | 1 |
| Undergraduate Degree | 1 |
Sektoral
| Health Technology | 3 |
| Consumer Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| ALLARITY THERAPEUTICS, INC. | Health Technology |
| Private Unternehmen | 1 |
|---|---|
Allarity Therapeutics A/S
Allarity Therapeutics A/S Pharmaceuticals: MajorHealth Technology Allarity Therapeutics A/S is a biotechnology company, which engages in the research and development of anti-cancer drugs. Its product pipeline includes LiPlaCis, 2X-121, 2X-111, irofulven phase 2, and APO010.The company was founded by Steen Meier Knudsen and Peter Buhl Jensen in 2004 and is headquartered in Hoersholm, Denmark. | Health Technology |
- Börse
- Insiders
- Joan Brown
- Erfahrung
